Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (441-450 of 606) with videos related to

Pageof 61
Sort By:
Allergy|July 18, 2025
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based ApproachOliver Pfaar, Ralph Mösges, Michael S Blaiss, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2025
Change, Career Transitions, and Retirement in Allergy-ImmunologyMelinda Rathkopf, Ray S Davis, Dana V Wallace, et al.
ACR Open Rheumatology|July 3, 2026
DNASE1L3 Deficiency With Novel Missense Variant: Enzymatic and Plasma Fragmentomic Evidence of Pathogenicity and Partial Response to JAK BlockadeAnnel Andrea Leon Tenorio, Takeshi Sugio, Jordan Cheng, et al.
Elife|July 27, 2016
A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patientsYishan Sun, Sergiu P Paşca, Thomas Portmann, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Which Score for What? Operationalizing Standardized Cognitive Test Performance for the Assessment of ChangeCristan Farmer, Audrey Thurm, Tanvi Das, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Making the GRADE in anaphylaxis management: Toward recommendations integrating values, preferences, context, and shared decision makingMarcus S Shaker, John Oppenheimer, Dana V Wallace, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Genetic Variants in Recurrent Euploid Pregnancy LossMona Aminbeidokhti, Michelle Halstead, Marta Rodriquez-Escriba, et al.
Nature|August 15, 2014
Inappropriate p53 activation during development induces features of CHARGE syndromeJeanine L Van Nostrand, Colleen A Brady, Heiyoun Jung, et al.
The World Allergy Organization Journal|April 3, 2019
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin AmericaIvan Cherrez-Ojeda, Marcus Maurer, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|March 2, 2024
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trialsMarcus Maurer, Thomas B Casale, Sarbjit S Saini, et al.
Pageof 61

Showing results (441-450 of 606) with videos related to

Sort By:
Pageof 61
Allergy|July 18, 2025
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based ApproachOliver Pfaar, Ralph Mösges, Michael S Blaiss, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2025
Change, Career Transitions, and Retirement in Allergy-ImmunologyMelinda Rathkopf, Ray S Davis, Dana V Wallace, et al.
ACR Open Rheumatology|July 3, 2026
DNASE1L3 Deficiency With Novel Missense Variant: Enzymatic and Plasma Fragmentomic Evidence of Pathogenicity and Partial Response to JAK BlockadeAnnel Andrea Leon Tenorio, Takeshi Sugio, Jordan Cheng, et al.
Elife|July 27, 2016
A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patientsYishan Sun, Sergiu P Paşca, Thomas Portmann, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Which Score for What? Operationalizing Standardized Cognitive Test Performance for the Assessment of ChangeCristan Farmer, Audrey Thurm, Tanvi Das, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2020
Making the GRADE in anaphylaxis management: Toward recommendations integrating values, preferences, context, and shared decision makingMarcus S Shaker, John Oppenheimer, Dana V Wallace, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Genetic Variants in Recurrent Euploid Pregnancy LossMona Aminbeidokhti, Michelle Halstead, Marta Rodriquez-Escriba, et al.
Nature|August 15, 2014
Inappropriate p53 activation during development induces features of CHARGE syndromeJeanine L Van Nostrand, Colleen A Brady, Heiyoun Jung, et al.
The World Allergy Organization Journal|April 3, 2019
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin AmericaIvan Cherrez-Ojeda, Marcus Maurer, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|March 2, 2024
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trialsMarcus Maurer, Thomas B Casale, Sarbjit S Saini, et al.
Pageof 61